Among these, FGFR2 fusions—particularly FGFR2-BICC1—are the most common genetic alterations in intrahepatic CCA (iCCA), activating MAPK and PI3K/mTOR pathways. This evidence concerns the gene MTOR and cholangiocarcinoma.